KCNMB2
Calcium-activated potassium channel subunit beta-2
Also known as: KCMB2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y691
- Gene
- KCNMB2
- Ensembl
- ENSG00000197584
- Chromosome
- 3
- Canonical length
- 235 aa
- Protein class
- FDA approved drug targets, Predicted membrane proteins, Transporters
OverviewNCBI Gene
MaxiK channels are large conductance, voltage and calcium-sensitive potassium channels which are fundamental to the control of smooth muscle tone and neuronal excitability. MaxiK channels can be formed by 2 subunits: the pore-forming alpha subunit and the modulatory beta subunit. The protein encoded by this gene is an auxiliary beta subunit which decreases the activation time of MaxiK alpha subunit currents. Alternative splicing results in multiple transcript variants of this gene. Additional variants are discussed in the literature, but their full length nature has not been described. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
235 residues, UniProt reviewed canonical sequence.
>Q9Y691|KCNMB2
1 MFIWTSGRTS SSYRHDEKRN IYQKIRDHDL LDKRKTVTAL KAGEDRAILL GLAMMVCSIM
61 MYFLLGITLL RSYMQSVWTE ESQCTLLNAS ITETFNCSFS CGPDCWKLSQ YPCLQVYVNL
121 TSSGEKLLLY HTEETIKINQ KCSYIPKCGK NFEESMSLVN VVMENFRKYQ HFSCYSDPEG
181 NQKSVILTKL YSSNVLFHSL FWPTCMMAGG VAIVAMVKLT QYLSLLCERI QRINRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KCNMB2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 33 nTPM
- fallopian tube: 13 nTPM
- ovary: 10 nTPM
- heart muscle: 5.4 nTPM
- adrenal gland: 4.8 nTPM
- hippocampal formation: 4.5 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 2,626 nCPM
- ependymal cells: 1,529 nCPM
- epicardial cells: 357 nCPM
- brain inhibitory neurons: 321 nCPM
- brain excitatory neurons: 279 nCPM
- cardiomyocytes: 162 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 8 nTPM
- hippocampal formation: 8 nTPM
- medulla oblongata: 6.2 nTPM
- midbrain: 5.4 nTPM
- basal ganglia: 5.1 nTPM
- amygdala: 4.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.57
- gnomAD pLI
- 0.55
- gnomAD missense Z
- 0.86
- DepMap mean gene effect
- 0.22
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- action potential
- detection of calcium ion
- neuronal action potential
- potassium ion transport
- regulation of vasoconstriction
Molecular functions
- calcium-activated potassium channel activity
- ion channel inhibitor activity
- potassium channel regulator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Potassium channel, calcium-activated, BK, beta subunit
- Calcium-activated potassium channel, beta subunit
- KCNMB2, ball/chain domain
- KCNMB2, ball/chain domain superfamily
- KCNMB2, ball and chain domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KCNMB2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KCNMB2 as an antibody target. Whether an autoantibody or antibody against KCNMB2 could matter depends on whether native KCNMB2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KCNMB2 is annotated at the cell surface, where native KCNMB2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KCNMB2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...